• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/25

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

25 Cards in this Set

  • Front
  • Back
Learning objectives
Cite the bacterial factors that contribute to the pathogenesis of UTIs

Cite the host factors that contribute to the pathogenesis of UTIs

Know the major differences between the microbiology of community-acquired vs nosocomial UTIs

Understand the role of urinalysis and quantitative urine cultures in the diagnosis of UTI

Understand why males with UTI need to have further evaluation for anatomic abnormalities

Know the differences in duration of therapy for cystitis, pyelonephritis, and prostatitis
UTI background
UTIs are the most common infection encountered in the outpatient setting
Common problem in hospitalized patients, particularly those with urinary catheters
Clinical manifestations differ based on affected portion of urinary tract
Treatment regimen differs based on anatomic location of infection
Bacteriuria
Pyuria
Cystitis
Complicated UTI
Pyelonephritis
Prostatitis
Bacteriuria: ≥10^5 organisms per milliliter

Pyuria: >10 wbc per high power field

Cystitis: inflammation/infection of the bladder

Complicated UTI: anatomic, functional or pharmacologic factors (also men and catheter) that predispose the patient to persistent infection recurrent infection or treatment failure

Pyelonephritis: infection of kidney

Prostatitis: infection of prostate
UTI Pathogenesis: Bacterial factors (7)
1. Increased bacterial adherence to uroepithelial cells
-Mediated via fimbria (also called pili)
-Two important types in E. coli
--Type 1 fimbriae
--P fimbriae
2. Resistance to serum cidal activity
-Evades normal host defenses
3. Hemolysin production
-Cell toxin, important in pyelonephritis
4. Ability to synthesize essential amino acids
-Guanine, arginine and glutamine required for bacterial growth in urine
5. Urease production (Proteus mirabilis)
-Important in pyelonephritis and urolithiasis
6. Bacterial motility
-Ascend against urine flow
7. Endotoxin production
-Decreases ureteral peristalsis
Type 1 and P fimbriae
Seen in E.coli

Type 1 fimbriae (mannose-sensitive)
-Adhere to mannosylated proteins on uroepithelial cells, can be detached by exposure to mannose
-Bacterial tropism for bladder (cystitis)

P fimbriae (mannose-resistant)
-Adhere to glycophospholipids embedded in outer surface of plasma membrane of uroepithelial cells
-Tropism for upper urinary tract (pyelonephritis)

TMP-SMX reduces synthesis and expression of fimbria adhesion molecules
Different E.coli strains
Pyelonephritis
-76% P fimbriae
-60% produce hemolysin

Most cystitis, asymptomatic bacteruria, and fecal flora don't have P fimbriae and hemolysis
UTI Pathogenesis: Host factors (6)
1. Obstruction or reflux
-Urethral stenosis
-Posterior urethral valves
-Kidney stones
-Polycystic kidney disease
-Spinal cord injury or neurogenic bladder (incomplete bladder emptying)
-Prostatic hypertrophy
-Pregnancy
2. Short urethra (10-20% of women will develop a symptomatic UTI in their lifetime
3. Bacterial colonization of vagina (periurethra)
4. Sexual intercourse
-Facilitates movement of bacteria from anterior urethra to bladder
-Trauma to urethra
-Diaphragm use (can cause urethral trauma)
-Spermacide use (inhibit lactobacillus)
5. Bladder catheterization (bypasses urethra)
-100% of patients will have bacteriuria within 3 days of catheter placement
6. Susceptibility of renal medulla
-High ammonia concentrations inactivate complement
-High osmolality inhibits migration of PMNs
UTI microbiology: community vs nosocomial
Outpatient setting:
-E. coli is #1
-Followed by Klebsiella and Proteus spp.

Inpatient setting:
-E. coli still #1
-Microbiology is more diverse, other GNR #2
-Pseudomonas and Candida
UTI microbiology: other points
UTIs are most often caused by a single organism
-Polymicrobial infections more likely to occur in those with structural abnormalities of the urinary tract
Staphylococcus saprophyticus accounts for 5-15% of UTIs in young, sexually active females
Staphylococcus epidermidis is an important nosocomial pathogen
Cystitis clinical manifestations
Dysuria
Frequency
Urgency
Suprapubic pain
Pyelonephritis clinical manifestations
Fever
Chills
Flank pain
Costovertebral angle tenderness
Nausea and vomitting
Hypotension
Tachycardia
Plus: symptoms of cystitis may be present
Asymptomatic bacteriuria clinical manifestations
Bacteria in the urine with NO symptoms

≥10^5 cfu/mL = positive urine culture

It does NOT prove infection; it is just a number to state that the culture is unlikely due to contamination

Pyuria also is not predictive on its own

It is the presence of symptoms AND pyuria AND bacteruria that denotes infection
Treatment of asymptomatic bacteriuria in the elderly
Multiple prospective randomized clinical trials have shown no benefit
No improvement in “mental status”
No difference in the number of symptomatic UTIs
No improvement in chronic urinary incontinence
No improvement in survival
Treatment of asymptomatic bacteriuria
Screen and Treat ASB in 2 scenarios:
-Pregnancy
-Patients undergoing urologic procedure in which bleeding is anticipated

Children

Otherwise, DO NOT TREAT
Urethritis: clinical manifestations and causes
Primary symptom: burning on urination
No frequency or urgency
Urine culture colony counts lower

Causes:
-Chlamydia trachomatous and Neisseria gonorrhoeae (purulent discharge from the urethra)
-Ureaplasma urealyticum
-noninfectious (trauma, allergic and chemical)
Prostatitis: clinical manifestations, PE findings, treatment
Fevers, Chills
Dysuria
Urinary frequency
Bladder outlet obstruction can occur

PE: high fever, may appear septic, moderate tenderness of suprapubic region
Rectal exam: exquisitely tender and diffusely enlarged prostate

Prostatic massage contraindicated
ABX Therapy should be prolonged (4-6 weeks) as most abx do not penetrate well into acidic, lipophilic environment of the prostate
UTI: diagnosis
Symptoms plus pyuria on urine dipstick or urinalysis

Urine dipstick: leukocyte esterase is rapid, sensitive

U/A required for evaluation of complicated UTI
-Centrifuge x 5 min at 2000 rpm
-Examine the sediment at high power
- > 10 WBC/hpf = pyuria
- White blood cell casts can be seen in pyelonephritis
Urine gram stain
Should be performed in all pts with suspected pyelonephritis
> 1 bacteria/hpf correlates with > 10^5 organisms/ml
In combination with pyuria and symptoms = infection
Urine culture
Should be performed in all patients EXCEPT young, sexually active women with suspected cystitis
-Recurrent UTI
-Pyelonephritis
-Catheter-associated urinary tract infection

Urine in the bladder is normally sterile, but urethra and periurethral areas are very difficult to sterilize, particularly in woman

Statistically differentiate using quantitative culture of midstream clean-voided urine
Anatomic investigations
All upper tract disease
Relapse or failure to improve after appropriate abx therapy
Preschool girls after their second UTI
UTI in males of any age
Anatomic investigations: diagnostic tests
Ultrasonography - sensitive, specific, inexpensive and safe. Test of choice.

CT scan - To exclude the diagnosis of perinephric abscess (no response to 48 hrs therapy in a patient with pyelonephritis)

Intravenous pyelogram - after abnormal ultrasonogram
Uncomplicated cystitis: treatment
Short course therapy (3-5 days)
-Nitrofurantoin
-Trimethoprim-Sulfamethoxazole (TMP-SMX)
-Ciprofloxacin

β-lactams are an alternative (3-7 days) (don't need to memorize list):
-Amoxicillin-clavulanate
-Cefdinir
-Cefaclor
-Cefpodoxime
When not to use short course therapy
Males
Upper tract symptoms (pyelonephritis)
Recurrent or relapse of symptoms
> 7 days of symptoms
Treatment of pyelonephritis
All patients should have urine culture and susceptibility test performed

Adjust antibiotics based on the results

7-14 days of antibiotics
-Intravenous ceftriaxone
-Oral if nontoxic and able to tolerate p.o.
--Ciprofloxacin
--TMP-SMX
Prevention of UTI
Sexually active women should void immediately after intercourse

Post-coital prophylaxis can be considered in sexually active women with recurrent UTIs
-TMP-SMX
-Nitrofurantoin

Cranberry juice or concentrated tablets may be effective in preventing cystitis (particularly in elderly women)

Intravaginal estrogen may be effective in preventing cystitis in elderly women with atrophic vaginitis

Long-term antibiotic prophylaxis
-NOT effective
-Causes antibiotic resistance

In-and-out straight catheterization preferable to indwelling catheterization in patients who are unable to void on their own